Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma
Authors
Keywords
-
Journal
Molecular Medicine Reports
Volume 8, Issue 2, Pages 456-462
Publisher
Spandidos Publications
Online
2013-06-11
DOI
10.3892/mmr.2013.1517
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Accurate Classification of Non-Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach
- (2010) J. A. Bishop et al. CLINICAL CANCER RESEARCH
- Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers
- (2010) Lei Yu et al. INTERNATIONAL JOURNAL OF CANCER
- A putative role for microRNA-205 in mammary epithelial cell progenitors
- (2010) S. B. Greene et al. JOURNAL OF CELL SCIENCE
- Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis
- (2010) Ying Xin WANG et al. Journal of Digestive Diseases
- Low-Level Expression of MicroRNAs let-7d and miR-205 Are Prognostic Markers of Head and Neck Squamous Cell Carcinoma
- (2009) Geoffrey Childs et al. AMERICAN JOURNAL OF PATHOLOGY
- Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy
- (2009) Hisashi Saji et al. ANTI-CANCER DRUGS
- Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization
- (2009) R. Popovic et al. BLOOD
- MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer
- (2009) M. Raponi et al. CANCER RESEARCH
- MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival
- (2009) E. A. Mathe et al. CLINICAL CANCER RESEARCH
- TargetingmiR-205in breast cancer
- (2009) Hailong Wu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Review Article: A Reevaluation of the Clinical Significance of Histological Subtyping of Non—Small-Cell Lung Carcinoma: Diagnostic Algorithms in the Era of Personalized Treatments
- (2009) Giulio Rossi et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
- (2009) Danit Lebanony et al. JOURNAL OF CLINICAL ONCOLOGY
- Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
- (2009) Tudor Ciuleanu et al. LANCET
- Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
- (2009) Cesare Gridelli et al. LUNG CANCER
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells
- (2009) Carl Christoph Schimanski et al. WORLD JOURNAL OF GASTROENTEROLOGY
- miR-375 Targets 3'-Phosphoinositide-Dependent Protein Kinase-1 and Regulates Glucose-Induced Biological Responses in Pancreatic -Cells
- (2008) A. El Ouaamari et al. DIABETES
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- An Alternative Method for Screening EGFR Mutation Using RFLP in Non-small Cell Lung Cancer Patients
- (2008) Ichiro Kawada et al. Journal of Thoracic Oncology
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More